JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Uso de metabolomía no dirigida para el estudio de trastornos neurometabolicos pediátricos: una revisión

  • 0Norwegian National Unit for Diagnostics of Congenital Metabolic Disorders, Department of Medical Biochemistry, Oslo University Hospital, PB 4950 Nydalen, 0424 Oslo, Norway; European Reference Network for Hereditary Metabolic Disorders (MetabERN), 0424 Oslo, Norway.
Molecular Genetics and Metabolism +

|

3 de enero de 2026

|

3 de enero de 2026

Resumen

No abstract available on PubMed

Palabras clave:

Videos de Conceptos Relacionados

Pharmacokinetics in Pediatric Patients: Drug Metabolism 01:24

171

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Inborn Errors of Metabolism 01:20

679

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption 01:23

225

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...